Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1993 1
1994 2
1998 1
1999 1
2001 3
2005 1
2008 2
2009 1
2010 1
2011 1
2012 3
2014 1
2017 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
Epstein JI, Amin MB, Fine SW, Algaba F, Aron M, Baydar DE, Beltran AL, Brimo F, Cheville JC, Colecchia M, Comperat E, da Cunha IW, Delprado W, DeMarzo AM, Giannico GA, Gordetsky JB, Guo CC, Hansel DE, Hirsch MS, Huang J, Humphrey PA, Jimenez RE, Khani F, Kong Q, Kryvenko ON, Kunju LP, Lal P, Latour M, Lotan T, Maclean F, Magi-Galluzzi C, Mehra R, Menon S, Miyamoto H, Montironi R, Netto GJ, Nguyen JK, Osunkoya AO, Parwani A, Robinson BD, Rubin MA, Shah RB, So JS, Takahashi H, Tavora F, Tretiakova MS, True L, Wobker SE, Yang XJ, Zhou M, Zynger DL, Trpkov K. Epstein JI, et al. Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493. doi: 10.5858/arpa.2020-0015-RA. Arch Pathol Lab Med. 2021. PMID: 32589068 Free article. Review.
CONTEXT.-: Controversies and uncertainty persist in prostate cancer grading. OBJECTIVE.-: To update grading recommendations. ...Intraductal carcinoma (IDC-P) is as follows: (1) report IDC-P in biopsy and RP; (2) use criteria based on dense cribriform glands (>50% …
CONTEXT.-: Controversies and uncertainty persist in prostate cancer grading. OBJECTIVE.-: To update grading recommendations. ...Intra …
Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.
Fine SW. Fine SW. Adv Anat Pathol. 2012 Jul;19(4):204-16. doi: 10.1097/PAP.0b013e31825c6b92. Adv Anat Pathol. 2012. PMID: 22692283 Review.
Beyond the typical acinar morphology observed in the majority of prostatic adenocarcinomas, a spectrum of morphologic variants and prostate cancer subtypes exists. These unusual entities may be classified as: (1) cancer morphologies arising by divergent differentiat …
Beyond the typical acinar morphology observed in the majority of prostatic adenocarcinomas, a spectrum of morphologic variants and …
Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach.
Helpap B. Helpap B. Virchows Arch. 1998 Nov;433(5):397-405. doi: 10.1007/s004280050266. Virchows Arch. 1998. PMID: 9849853 Review.
A variety of small acinar lesions of the prostate can mimic prostate cancer in punch biopsies and in transurethral resection material. The first part of this review deals with differential diagnostic problems of the central and transition zone, including atypical ad …
A variety of small acinar lesions of the prostate can mimic prostate cancer in punch biopsies and in transurethral resection m …
Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Paner GP, Luthringer DJ, Amin MB. Paner GP, et al. Arch Pathol Lab Med. 2008 Sep;132(9):1388-96. doi: 10.5858/2008-132-1388-BPIDIP. Arch Pathol Lab Med. 2008. PMID: 18788849 Free article. Review.
CONTEXT: The unrelenting challenge encountered when differentiating limited-volume prostate carcinoma and sometimes subtle variants from its many morphologic mimics has increased the use of ancillary immunohistochemistry in routine prostate needle biopsies. T …
CONTEXT: The unrelenting challenge encountered when differentiating limited-volume prostate carcinoma and sometimes subtle var …
Uncommon Cervical Lesions: A Review and Discussion of the Differential Diagnosis.
Griesinger LM, Szczepanski JM, McMullen ER, Skala SL. Griesinger LM, et al. Arch Pathol Lab Med. 2021 Jul 1;145(7):891-902. doi: 10.5858/arpa.2020-0327-RA. Arch Pathol Lab Med. 2021. PMID: 33091926 Free article.
.-: While the vast majority of cervical tumors consist of human papillomavirus (HPV)-related squamous cell carcinoma or adenocarcinoma, a subset of rare tumor types, frequently unrelated to HPV, does occur in this location. ...Some are benign or portend a favorable …
.-: While the vast majority of cervical tumors consist of human papillomavirus (HPV)-related squamous cell carcinoma or adenoc …
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.
Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, Baras AS, DeMarzo AM, Cheville JC, Jimenez RE, Trpkov K, Colecchia M, Ro JY, Montironi R, Menon S, Hes O, Williamson SR, Hirsch MS, Netto GJ, Fine SW, Sirohi D, Kaushal S, Sangoi A, Robinson BD, Kweldam CF, Humphrey PA, Hansel DE, Schultz L, Magi-Galluzzi C, Przybycin CG, Shah RB, Mehra R, Kunju LP, Aron M, Kryvenko ON, Kench JG, Kuroda N, Tavora F, van der Kwast T, Grignon DJ, Epstein JI, Reuter VE, Amin MB. Gandhi JS, et al. Am J Surg Pathol. 2020 May;44(5):673-680. doi: 10.1097/PAS.0000000000001417. Am J Surg Pathol. 2020. PMID: 31876580
Intraductal carcinoma of the prostate (IDC-P) has been recently recognized by the World Health Organization classification of prostatic tumors as a distinct entity, most often occurring concurrently with invasive prostatic adenocarcinoma (PCa). ...More …
Intraductal carcinoma of the prostate (IDC-P) has been recently recognized by the World Health Organization classification of …
The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland.
Jones EC, Young RH. Jones EC, et al. Am J Clin Pathol. 1994 Jan;101(1):48-64. doi: 10.1093/ajcp/101.1.48. Am J Clin Pathol. 1994. PMID: 7506479 Review.
The understanding of prostate pathology has progressed, and the differential diagnosis of prostatic carcinoma has expanded to include possible premalignant lesions and several recently described pseudocarcinomatous lesions. ...Pseudocarcinomatous lesions that …
The understanding of prostate pathology has progressed, and the differential diagnosis of prostatic carcinoma has expan …
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
González Del Alba A, Arranz JÁ, Puente J, Méndez-Vidal MJ, Gallardo E, Grande E, Pérez-Valderrama B, González-Billalabeitia E, Lázaro-Quintela M, Pinto Á, Lainez N, Piulats JM, Esteban E, Maroto Rey JP, García JA, Suárez C. González Del Alba A, et al. Crit Rev Oncol Hematol. 2017 May;113:171-190. doi: 10.1016/j.critrevonc.2017.03.010. Epub 2017 Mar 14. Crit Rev Oncol Hematol. 2017. PMID: 28427506 Review.
While sunitinib and pazopanib continue to be the standard first-line treatment in metastatic renal cell carcinoma of clear cell histology, nivolumab and cabozantinib are now the agents of choice in the second-line setting. ...Chemotherapy has been consolidate …
While sunitinib and pazopanib continue to be the standard first-line treatment in metastatic renal cell carcinoma of clear …
Diagnosis and treatment of prostate cancer in renal-transplant recipients.
Binsaleh S. Binsaleh S. Int Urol Nephrol. 2012 Feb;44(1):149-55. doi: 10.1007/s11255-011-9988-8. Epub 2011 May 26. Int Urol Nephrol. 2012. PMID: 21614508
RESULTS: Of the 498 male renal-transplant patients, nine were diagnosed with prostate cancer. A prostate specific antigen (PSA) screening program was not utilized, and these patients were diagnosed based on a prostate digital rectal examination and/or elevate …
RESULTS: Of the 498 male renal-transplant patients, nine were diagnosed with prostate cancer. A prostate specific antigen (PSA …
Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate.
Shah RB, Zhou M. Shah RB, et al. Adv Anat Pathol. 2012 Jul;19(4):270-8. doi: 10.1097/PAP.0b013e31825c6c0e. Adv Anat Pathol. 2012. PMID: 22692290 Review.
Atypical cribriform lesions of the prostate gland consist of cribriform and rarely solid proliferation of prostate glands populated with cytologically atypical cells with partial or complete basal cell lining. It may represent cribriform "high-grade …
Atypical cribriform lesions of the prostate gland consist of cribriform and rarely solid proliferation of prostate glands popu …
21 results